Molly Harper

Director, Catalyst Pharmaceuticals.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 15, 2026Returned to company 3,694 shares at $31.50 of Catalyst Pharmaceuticals²
Dec 29, 2025Exercised options 1,334 shares of Catalyst Pharmaceuticals³
Dec 12, 2025Sold 6,746 shares at $23.06 of Catalyst Pharmaceuticals⁴
Dec 12, 2025Sold 4,473 shares at $23.73 of Catalyst Pharmaceuticals⁴
Dec 12, 2025Sold 15,527 shares at $23.20 of Catalyst Pharmaceuticals⁴
Dec 12, 2025Exercised options 20,000 shares at $5.78 of Catalyst Pharmaceuticals⁴
Dec 8, 2025Exercised options 1,413 shares of Catalyst Pharmaceuticals⁵
Nov 21, 2025Exercised options 947 shares of Catalyst Pharmaceuticals⁶
Feb 14, 2025Exercised options 4,000 shares of Catalyst Pharmaceuticals⁷
Dec 27, 2024Exercised options 1,333 shares of Catalyst Pharmaceuticals⁸
Dec 9, 2024Exercised options 1,413 shares of Catalyst Pharmaceuticals⁹
Nov 27, 2024Sold 17,500 shares at $22.00 of Catalyst Pharmaceuticals¹⁰
Nov 27, 2024Exercised options 17,500 shares at $5.78 of Catalyst Pharmaceuticals¹⁰
Jun 3, 2024Sold 5,333 shares at $16.30 of Catalyst Pharmaceuticals¹¹
Feb 15, 2024Exercised options 4,000 shares of Catalyst Pharmaceuticals¹²
Dec 27, 2023Exercised options 1,333 shares of Catalyst Pharmaceuticals¹³
Dec 15, 2023Sold 10,000 shares at $14.37 of Catalyst Pharmaceuticals¹⁴
Dec 15, 2023Exercised options 10,000 shares at $5.78 of Catalyst Pharmaceuticals¹⁴
Dec 15, 2023Sold 4,000 shares at $14.43 of Catalyst Pharmaceuticals¹⁴
Feb 15, 2023Exercised options 4,000 shares of Catalyst Pharmaceuticals¹⁵

The numbers on this page point here. Each one links to the record it came from.